A new medical journal launched by the Independent Medical Alliance aims to counter what its founder describes as ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

The European pharmaceutical and biotechnology market offers vast opportunities. The European Pharmaceutical Directory aids businesses by providing up-to-date contact information, profiles, and ...

It’s time for Oklahoma to demand transparency and accountability so innovation, not influence, determines patient care.

This pharmaceutical giant is increasingly looking unstoppable.

Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp ...

Introducing Pharmony At this critical time, the PM Society is launching Pharmony, a positive, evidence-led response to counter the negativity and uncertainty that dominates. It’s an initiative that ...

Large drugmakers once had more room to absorb failure, both financially and reputationally | Large drugmakers are facing tighter constraints than in the past, as financial, scientific and reputational ...

The global pharmaceuticals market is estimated to reach $1.21 trillion in 2025, according to Statista data. Overall, Statista predicted the worldwide pharma industry market revenue will increase 4.5% ...

Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should embrace it.

PharmTech is rebranding to strengthen its commitment to scientists, innovators, and executives in the pharmaceutical industry. The company is introducing a new look, refined content strategy, and ...